Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2011 Apr;57(4):400–406. doi: 10.1097/FJC.0b013e31820b7df1

Figure 2.

Figure 2

The computed absolute change in plasma PLact compared to baseline, reflective of changes in PLact, following low/high dose aprotinin infusions. Plasma PLact initially declined at 30 minutes, followed by a relative transient rise and subsequent progressive decrease with significant inhibition in PLact at 120 minutes post infusion for both the low and high dose groups (plotted values are mean±SEM, # p < 0.05 low dose verses baseline; * p < 0.05 high dose verses baseline).